This is the authors' abstract. We don't add key points for this paper.
The deficiency of retinoblastoma ( Rb ) gene deregulates E2F transcription factors and thus induces E2F target genes directly or p53 target genes indirectly via mouse p19 Arf (or p14 ARF in humans), an E2F target gene. Here, we identified that etoposide-induced 2.4 mRNA ( Ei24 )/p53-induced gene 8 ( Pig8 ), a p53 target gene involved in apoptosis and autophagy, was up-regulated in Rb −/− mouse embryonic fibroblasts (MEFs). The Ei24 promoter was activated by E2F1 via multiple E2F-responsive elements, independently of the previously reported p53-responsive element. Chromatin immunoprecipitation assays revealed that E2F1 directly acts on the mouse Ei24 promoter. We observed that Ei24 expression was suppressed in p53 −/− MEFs upon UVC irradiation, which was exacerbated in p53 −/− E2f1 −/− MEFs, supporting the positive role of E2F1 on Ei24 transcription. Furthermore, Ei24 knockdown sensitized p53 −/− MEFs against UVC irradiation. Together, our data indicate that Ei24 is a novel E2F target gene contributing to the survival of p53 -deficient cells upon UVC irradiation and thus may have a potential significance as a therapeutic target of certain chemotherapy for treating p53 -deficient tumors. Background: Rb loss deregulates E2F and thus induces the expressions of E2F target genes. Results: Ei24 is an E2F target up-regulated in Rb −/− MEFs and affects susceptibility of p53 -deficient MEFs against UVC. Conclusion: E2F1 can provide a p53-independent modulation of cellular sensitivity against UVC via Ei24 . Significance: EI24 may be a potential therapeutic target for treating p53 -deficient tumors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sung et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: